SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is a major talking point as the community keenly watches for a decisive move above a critical resistance level, with many anticipating a rally beyond previous highs. This upward momentum is fueled by positive sentiment around increasing institutional demand, progress toward regulatory clarity, and macroeconomic signals like cooling inflation. However, some market participants remain cautious, suggesting potential rejections at current levels before any sustained breakout.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is capturing significant attention following a notable price rally, driven by increasing institutional staking activity and fresh optimism surrounding potential spot ETF approvals. The community is buzzing with short squeeze narratives and growing confidence in Ethereum's pivotal role in DeFi, stablecoins, and the broader tokenization of real-world assets, anticipating further upside.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending due to reports of considering an all-cash bid for Warner Bros. Discovery, which the community is largely viewing as a bullish signal for avoiding dilution and indicating strong upcoming earnings. This comes amid an escalating takeover battle with Paramount, while many anticipate a pre-earnings rally or short squeeze ahead of its highly awaited report.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is a hot topic as investors analyze unaudited Q4 revenue and 2026 guidance for its multiple sclerosis treatment, Briumvi, ahead of an anticipated presentation at a major healthcare conference. The community is buzzing about Briumvi's strong market adoption and competitive advantages, further bolstered by recent issues impacting rival treatments. Despite operational strength, widespread discussion centers on the stock's valuation and the ongoing debate between its fundamental growth and market sentiment.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies Inc. ($BMNR) is a major focus for investors due to an impending shareholder vote on a significant increase in authorized shares and executive compensation, generating intense debate. Many retail investors voice strong concerns about potential massive dilution and the stock's notable underperformance relative to Ethereum's price movements, leading to widespread criticism of management. The community is actively discussing whether this vote will enable future growth through its Ethereum staking strategy or further erode shareholder value.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is surging amid positive financial outlook revisions and ongoing regulatory progress for its next-generation COVID and flu vaccines, complemented by funding for a pandemic flu trial. Community discussion centers on the company's perceived undervaluation and the long-term potential of its diverse mRNA pipeline, particularly in oncology, with many anticipating a substantial short squeeze. This renewed interest highlights a broader re-evaluation of Moderna's platform capabilities within the evolving biotech landscape.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending amid a barrage of analyst downgrades, as concerns over a challenging AI technology transition and intensifying competition from rival creative software and AI tools fuel a heated debate among investors. While many view the stock as overvalued and vulnerable to disruption, a significant segment of the community sees the recent dip as a compelling buying opportunity, emphasizing Adobe's strong fundamentals and strategic AI integrations for long-term growth.

Memecoin on Injective taken over by the community.

Nonja

NONJA CRYPTO is trending as a high-leverage meme coin on the Injective blockchain, with its dedicated community rallying around its potential for significant gains. Enthusiasts view $NONJA as an unruggable asset with robust community engagement and burned liquidity, poised to amplify the anticipated growth of the fundamentally strong and often-discussed $INJ ecosystem.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending due to its strong Q3 earnings report, which exceeded EPS expectations and included an optimistic FY26 revenue forecast, significantly driven by the accelerating adoption of its AI-powered Agentforce platform. This has ignited bullish sentiment among investors who see the stock as deeply undervalued and poised for a rebound. However, community discussion continues to reflect broader market skepticism about AI's impact on traditional software licensing models and the stock's past volatility.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is experiencing significant volatility, primarily driven by continued discussions around executive share sales and recent concerns regarding new AI agent solutions entering the market. While some investors see market manipulation in the stock's rapid movements, many within the community view current levels as a compelling buying opportunity, emphasizing the company's robust balance sheet and its strategic position in the burgeoning agentic AI sector.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Whitehawk Therapeutics (NASDAQ:WHWK) Stock Price Down 2.7% - Here's What Happened

Whitehawk Therapeutics (NASDAQ:WHWK) Trading Down 2.7% - What's Next...

Whitehawk Therapeutics (NASDAQ:WHWK) Now Covered by Jones Trading

Jones Trading started coverage on Whitehawk Therapeutics in a research note on Monday. They issued a "buy" rating and a $7.00 price objective on the stock...

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer PR Newswire MORRISTOWN, N.J., Dec. 1, 2025...

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference PR Newswire...

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London PR Newswire MORRISTOWN...

What is HC Wainwright's Estimate for WHWK FY2025 Earnings?

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Free Report) - Research analysts at HC Wainwright cut their FY2025 earnings estimates for shares of Whitehawk Therapeutics in a note issued to investors on...

Whitehawk Therapeutics (NASDAQ:WHWK) Releases Quarterly Earnings Results, Beats Estimates By $0.25 EPS

Whitehawk Therapeutics (NASDAQ:WHWK - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus...

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights PR Newswire...

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC Whitehawk Therapeutics Presents Real-World...

Tempus AI Fuels Growth Through Strategic Biotech Collaborations

TEM expands its AI-driven growth with new collaborations in oncology, neurogenomics, and diagnostic innovation.

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.

Whitehawk Therapeutics Inc.

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.55	--	--	N/A
Q3 '25	-$0.51	-$0.26	49.02%	BEAT
Q2 '25	$0.82	-$0.76	-192.12%	MISSED
Q1 '25	--	$1.83	--	N/A

WHWK
Whitehawk Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest WHWK News

WHWKWhitehawk Therapeutics Inc.